Insulin-like growth factor-I and estrogen interactions in breast cancer

Journal of Nutrition

Volumn 132, Issue 12, 2002, Pages

  Martin, Mary Beth ^a   Stoica, Adriana ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Estradiol; Estrogen receptor; Insulin like growth factor I

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN; ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR;

BINDING AFFINITY; BREAST CANCER; CANCER RISK; CELL PROLIFERATION; CONFERENCE PAPER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0036900628     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.12.3799s     Document Type: Conference Paper

References (31)

1. Umayahava, Y., Kawamori, R., Watada, H., Imano, E., Iwana, N., Morishima, T., Yamasaki, Y., Kajimoto, Y. & Kamada, T. (1994) Estrogen regulation of the IGF-I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269: 16433-16442.
2. Yee, D. (1994) The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat. 32: 85-95.
3. Lee, A. V., Weng, C. N., Jackson, J. G. & Yee, D. (1997) Activation of ER-mediated gene transcription by IGF-I in human breast cancer cells. J. Endocrinol. 152: 39-47.
4. Rocha, R. L., Hilsenbeck, S. G., Jackson, J. G. & Yee, D. (1995) Insulin-like growth factor binding protein-3 (IGFBP-3) and insulin receptor substrate 1 (IRS1) in primary breast cancer: Larger tumors have higher IGFBP-3 levels and high levels of IRS-1 are associated with lower disease-free survival rate (DFS) rate. Breast Cancer Res. Treat. 137 (suppl): 55.
5. Guvakova, M. A. & Surmacz, E. (1997) Tamoxifen interferes with the IGF-I receptor signaling pathway in breast cancer cells. Cancer Res. 57: 2606-2610.
6. Surmacz, E. & Burgand, J. L. (1995) Overexpression of insulin receptor substrate-1 (IRS-I) in the human breast cancer cell line MCF-7 induces loss of estrogen requirement for growth and transformation. Clin. Cancer Res. 1: 1429-1436.
7. Guvakova, M. A. & Surmacz, E. (1997) Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp. Cell Res. 231: 149-162.
8. Cullen, K. J., Lippman, M. E., Chow, D., Hill, S., Rosen, N. & Zwiebel, J. A. (1992) Insulin-like growth factor II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol. 6: 91-100.
9. Stewart, A. J., Johnson, M. D., May, F. E. B. & Westley, B. R. (1990) Role of insulin-like growth factors and the type I IGF receptor in the estrogenstimulated proliferation of human breast cancer cells. J. Biol. Chem. 178: 21172-21178.
10. Ma, Z. Q., Santagati, S., Patrone, C., Pollio, G., Vegeto, E. & Maggi, A. (1994) Insulin growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol. Endocrinol. 8: 910-918.
11. Westley, B. R. & May, F. E. B. (1994) Role of insulin-like growth factors in steroid-modulated proliferation. J. Steroid Biochem. 51: 1-9.
12. Sahlin, L., Nostedt, G. & Eriksson, H. (1994) Estrogen regulation of the estrogen receptor and IGF-I in the rat uterus: A potential coupling between effects of estrogen and IGF-I. Steroids 59: 421-430.
13. Winston, R., Kao, P. C. & Kiang, D. T. (1994) Regulation of insulin-like growth factors by antiestrogen. Breast Cancer Res. Treat. 31: 107-115.
14. Davoodi, F., Brenner, R. V., Evans, S. R. T., Schumaker, L. M., Shabahang, M., Nauta, R. J. & Buras, R. R. (1995) Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 54: 147-153.
15. Renaud, J. P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. & Moras, D. (1996) Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (Lond.) 378: 681-689.
16. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (Lond.) 375: 377-382.
17. Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. & Carlquist, M. (1997) Molecular basis of agonism and antagonism in the estrogen receptor. Nature (Lond.) 389: 753-758.
18. Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D. & Fletterick, R. J. (1995) A structural role for hormone in the thyroid hormone receptor. Nature (Lond.) 378: 690-697.
19. Tanenbaum, D. M., Wang, Y., Williams, S. P. & Sigler, P. B. (1998) Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domain. Proc. Natl. Acad. Sci. U.S.A. 95: 5998-6003.
20. Smith, C. L. (1998) Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58: 627-632.
21. Orti, E., Bodwell, J. E. & Munck, A. (1992) Phosphorylation of steroid hormone receptors. Endocr. Rev. 13: 105-128.
22. Le Goff, P., Montano, M. M., Schodin, D. J. & Katzenellenbogen, B. S. (1994) Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269: 4458-4466.
23. Arnold, S. F., Obourn, J. D., Jaffe, H. & Notides, A. C. (1994) Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 8: 1208-1214.
24. Arnold, S. F., Obourn, J. D., Jaffe, H. & Notides, A. C. (1995) Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol. Endocrinol. 9: 24-33.
25. Chalbos, D., Philips, A., Galtier, F. & Rochefort, H. (1993) Synthetic antiestrogens modulate induction of pS2 and cathepsin D mRNA by growth factors and AMP in MCF-7 cells. Endocrinology 133: 571-576.
26. Stancel, G. M., Gardner, R. M., Kirland, J. L., Liu, T. H., Lingham, R. B., Loose-Mitchell, D. S., Mukku, V. R., Orengo, C. A. & Verner, G. (1987) Interactions between estrogen and EGF in uterine growth. Adv. Exp. Med. Biol. 230: 99-118.
27. Newton, C. J., Buric, R., Trapp, T., Brockmeier, S., Pagotto, U. & Stalla, G. K. (1994) The unliganded estrogen receptor transduces growth factor signals. J. Steroid Biochem. 48: 481-486.
28. Clayton, S. J., May, F. E. B. & Westley, B. R. (1997) IGFs control the regulation of ER and PR expression by estrogens. Mol. Cell Endocrinol. 128: 57-68.
29. Klotz, D. M., Hewitt, S. C., Ciana, P., Raviscioni, M., Lindzey, J. K., Foley, J., Maggi, A., DiAugustine, R. P. & Korach, K. S. (2002) Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J. Biol. Chem. 277: 8531-8537.
30. Stoica, A., Saceda, M., Fakhro, A., Joyner, M. & Martin, M. B. (2000) Role of insulin-related growth factor-I in the regulation of estrogen receptor-alpha gene expression. J. Cell Biochem. 76: 605-614.
31. Vanhaesebroeck, B. & Alessi, D. R. (2000) The PI3K-PDK1 connection: More than just a road to PKB. Biochem. J. 346 (pt 3): 561-576.